CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENT
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. KEY FINDINGS OF THE STUDY
2.2. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. PORTERS FIVE FORCES ANALYSIS
3.3.1. Bargaining power of buyers
3.3.2. Bargaining power of suppliers
3.3.3. Threat of substitutes
3.3.4. Threat of new entrants
3.3.5. Competitive rivalry
3.4. MARKET SHARE ANALYSIS OF MULTIPLEX ASSAYS MARKET, 2015
3.5. MARKET DYNAMICS
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
CHAPTER 4 MULTIPLEX ASSAYS MARKET, BY TYPE
4.1. OVERVIEW
4.1.1. Market Size and Forecast
4.2. NUCLEIC ACID-BASED MULTIPLEX ASSAYS
4.2.1. Key Market Trends
4.2.2. Key Growth Factors and Opportunities
4.2.3. Market Size and Forecast
4.2.4. Planar Nucleic Acid Multiplex Assays
4.2.5. Bead-Based Nucleic Acid Multiplex Assays
4.3. PROTEIN-BASED MULTIPLEX ASSAYS
4.3.1. Key Market Trends
4.3.2. Key Growth Factors And Opportunities
4.3.3. Market Size and Forecast
4.3.4. Planar Protein Multiplex Assays
4.3.5. Bead-Based Protein Multiplex Assays
4.4. OTHER MULTIPLEX ASSAYS
4.4.1. Key Market Trends
4.4.2. Key Growth Factors And Opportunities
4.4.3. Market Size And Forecast
CHAPTER 5 MULTIPLEX ASSAYS MARKET, BY PRODUCT
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. MULTIPLEX ASSAYS REAGENTS & CONSUMABLES
5.2.1. Market size and forecast
5.3. MULTIPLEX ASSAYS INSTRUMENTS AND ACCESSORIES
5.3.1. Market size and forecast
5.4. MULTIPLEX ASSAY SOFTWARE AND SERVICES
5.4.1. Market size and forecast
CHAPTER 6 MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY
6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. MULTIPLEX PCR
6.2.1. Market size and forecast
6.3. MULTIPLEX PROTEIN MICROARRAY
6.3.1. Market size and forecast
6.4. OTHER TECHNOLOGIES
6.4.1. Market size and forecast
CHAPTER 7 MULTIPLEX ASSAYS MARKET, BY APPLICATION
7.1. OVERVIEW
7.1.1. Market size and forecast
7.2. COMPANION DIAGNOSTICS
7.2.1. Market size and forecast
7.3. RESEARCH & DEVELOPMENT
7.3.1. Market size and forecast
7.3.2. Drug Development: Market Size and Forecast
7.3.3. Biomarker Discovery and Validation: Market Size and Forecast
7.4. CLINICAL DIAGNOSTICS
7.4.1. Market size and forecast
7.4.2. Cancer: Market Size and Forecast
7.4.3. Infectious Diseases: Market Size and Forecast
7.4.4. Cardiac Diseases: Market Size and Forecast
7.4.5. Autoimmune Diseases: Market Size and Forecast
7.4.6. Alzheimers Disease: Market Size and Forecast
7.4.7. Other Diseases: Market Size and Forecast
CHAPTER 8 MULTIPLEX ASSAYS MARKET, BY END USER
8.1. OVERVIEW
8.1.1. Market size and forecast
8.2. HOSPITALS
8.2.1. Market size and forecast
8.3. CLINICAL LABORATORIES
8.3.1. Market size and forecast
8.4. RESEARCH INSTITUTES
8.4.1. Market size and forecast
8.5. PHARMACEUTICALS & BIOTECHNOLOGICAL COMPANIES
8.5.1. Market size and forecast
CHAPTER 9 MULTIPLEX ASSAYS MARKET, BY GEOGRAPHY
9.1. OVERVIEW
9.1.1. Market size and forecast
9.2. NORTH AMERICA
9.2.1. Key market trends
9.2.2. Key growth factors and opportunities
9.2.3. Market size and forecast
9.2.4. U.S. market size and forecast
9.2.5. Canada market size and forecast
9.2.6. Mexico market size and forecast
9.3. EUROPE
9.3.1. Key market trends
9.3.2. Key growth factors and opportunities
9.3.3. Market size and forecast
9.3.4. Germany market size and forecast
9.3.5. France market size and forecast
9.3.6. UK market size and forecast
9.3.7. Italy market size and forecast
9.3.8. Spain market size and forecast
9.3.9. Rest of Europe market size and forecast
9.4. ASIA-PACIFIC
9.4.1. Key market trends
9.4.2. Key growth factors and opportunities.
9.4.3. Market size and forecast
9.4.4. Japan market size and forecast
9.4.5. China market size and forecast
9.4.6. India market size and forecast
9.4.7. Rest of Asia-Pacific market size and forecast
9.5. LAMEA
9.5.1. Key market trends
9.5.2. Key growth factors and opportunities
9.5.3. Market size and forecast
9.5.4. Latin America market size and forecast
9.5.5. Middle East market size and forecast
9.5.6. Africa market size and forecast
CHAPTER 10 COMPANY PROFILES
10.1. LUMINEX CORPORATION
10.1.1. Company overview
10.1.2. Company snapshot
10.1.3. Operating business segments
10.1.4. Product portfolio
10.1.5. Business performance
10.1.6. Key strategic moves and developments
10.2. THERMO FISHER SCIENTIFIC, INC.
10.2.1. Company overview
20.2.2. Company snapshot
20.2.3. Operating business segments
20.2.4. Product portfolio
20.2.5. Business performance
20.2.6. Key strategic moves and developments
10.3. ILLUMINA, INC.
10.3.1. Company overview
10.3.2. Company snapshot
10.3.3. Operating business segments
10.3.4. Product portfolio
10.3.5. Business performance
10.3.6. Key strategic moves and developments
10.4. BIO-RAD LABORATORIES, INC.
10.4.1. Company overview
10.4.2. Company snapshot
10.4.3. Operating business segments
10.4.4. Product portfolio
10.4.5. Business performance
10.4.6. Key strategic moves and developments
10.5. QIAGEN N.V.
10.5.1. Company overview
10.5.2. Company snapshot
10.5.3. Operating business segments
10.5.4. Product portfolio
10.5.5. Business performance
10.5.6. Key strategic moves and developments
10.6. BECTON, DICKINSON AND COMPANY
10.6.1. Company overview
10.6.2. Company snapshot
10.6.3. Operating business segments
10.6.4. Product portfolio
10.6.5. Business performance
10.6.6. Key strategic moves and developments
10.7. ABCAM PLC
10.7.1. Company overview
10.7.2. Company snapshot
10.7.3. Operating business segments
10.7.4. Product portfolio
10.7.5. Business performance
10.7.6. Key strategic moves and developments
10.8. SEEGENE INC.
10.8.1. Company overview
10.8.2. Company snapshot
10.8.3. Operating business segments
10.8.4. Product portfolio
10.8.5. Business performance
10.8.6. Key strategic moves and developments
10.9. MESO SCALE DIAGNOSTICS, LLC
10.9.1. Company overview
10.9.2. Company snapshot
10.9.3. Operating business segments
10.9.4. Product portfolio
10.9.5. Business performance
10.9.6. Key strategic moves and developments
10.10. RANDOX LABORATORIES LTD.
10.10.1. Company overview
10.10.2. Company snapshot
10.10.3. Operating business segments
10.10.4. Product portfolio
10.10.5. Business performance
10.10.6. Key strategic moves and developments